Zimmer Biomet Holdings, Inc. logo
Zimmer Biomet Holdings, Inc. (ZBH)
Compare

Zimmer Biomet Holdings, Inc. (ZBH) Price History:-2.85%(TTM)

Compare

Over the latest trailing 12-month period, Zimmer Biomet Holdings, Inc. (ZBH)'s price cagr is -2.85%. The comparable SPY value is +25.01%. Year-to-date price return is -2.28%. Price CAGR uses adjusted close price history and excludes dividends.

Current Price

$87.97

+$0.81 (+0.93%)

Previous Close: $87.16

Last Session

Open
$87.85
Day High
$88.81
Day Low
$87.32
Volume
4.63M
Avg Volume
2.32M

52-Week Position

30%

of the 52-week price range

From 52-week high
-18.76%
From 52-week low
+11.19%

52-Week Price Range

52-Week Low

$79.12

May 11, 2026

Current Price

$87.97

30% of range

52-Week High

$108.29

Aug 22, 2025

Low (+11.19% from current)(-18.76% from current) High

Price Returns by Period

1 Day

+0.93%

7 Days

-0.68%

30 Days

+3.12%

YTD

-2.28%

1 Year

-3.56%

vs 52W High

-18.76%

ZBH Price Chart

End-of-day pricesAdvanced chart →
ZBH$87.97 -3.86%(1Y)as of Jun 18, 2026

Long-Term Performance (CAGR)

Price CAGR (3Y)

-15.14%

Price CAGR (5Y)

-10.57%

Total Return CAGR (3Y)

-14.38%

Total Return CAGR (5Y)

-9.82%

CAGR (Compound Annual Growth Rate) shows the annualized return over the specified period. Total Return includes dividends reinvested.

Key Price Statistics

Current Price$87.97
Previous Close$87.16
Day Range$87.32 - $88.81
52-Week Range$79.12 - $108.29
Volume4.63M
Average Volume2.32M
Market Cap$17.02B
% from 52W High-18.76%
Data as of Saturday, June 20, 2026

About Zimmer Biomet Holdings, Inc.

Zimmer Biomet Holdings, Inc. (ZBH), along with its global subsidiaries, operates as a leading player in the musculoskeletal healthcare sector. The company extends its reach across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. ZBH is responsible for the design, manufacturing, and marketing of a wide array of orthopedic reconstructive solutions, including prominent knee and hip replacement systems. Their offerings also encompass Specialized Enabling Technologies (S.E.T.) products, which cover areas such as sports medicine, biologics, foot and ankle care, extremity treatments, and trauma management. Furthermore, the company provides medical devices and surgical instruments specifically for spinal conditions, alongside products for facial and cranial reconstruction. A unique part of their portfolio includes systems designed to stabilize and fixate chest bones, facilitating recovery or reconstruction following open-heart surgery, traumatic injuries, or congenital chest deformities. The company's product lines also feature a comprehensive range of dental solutions, such as reconstructive implants, prosthetics, and regenerative materials. Additionally, they are involved in robotic surgical systems, general surgical instruments, and bone cements. These advanced products and solutions are primarily utilized to address conditions in patients suffering from disorders or injuries affecting bones, joints, and their associated soft tissues. Zimmer Biomet caters to a broad clientele, including orthopedic, neuro-, and oral surgeons, dentists, hospitals, independent distributors, healthcare suppliers, and various other medical specialists. Their network further encompasses agents, healthcare purchasing organizations, and group buying alliances. Originally established in 1927, the enterprise was initially known as Zimmer Holdings, Inc., before rebranding as Zimmer Biomet Holdings, Inc. in June 2015. Its corporate headquarters are situated in Warsaw, Indiana.

Warsaw, IN
17,000 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Ivan Tornos